Skip to main content

Table 3 Clinical factors associated with sarcopenic obesity in patients with COPD

From: Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study

Variable

Sarcopenia obesity

Univariate analysis

 

Multivariate analysis

OR (95%CI)

P-vale

 

OR (95%CI)

P-vale

Age

1.107(1.007–1.217)

0.036

 

1.106(0.960–1.274)

0.163

Sex

0.452(0.128–1.595)

0.217

   

BMI

1.284(1.074–1.536)

0.006

 

1.474(1.124–1.934)

0.005

FEV1, %predicted

0.463(0.165–1.303)

0.145

   

Serum Resistin

1.001(1.000-1.001)

< 0.001

 

1.001(1.000-1.002)

0.001

Serum TNF-α

1.818(1.041–3.177)

0.036

 

2.055(0.895–4.720)

0.089

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us